Last week we had the opportunity to present Moehs to the students of the Master’s Degree in Pharmaceutical and Biotechnological Industry at UPF. The presentation consisted of an introduction to the reality of our company and, especially, to the day-to-day work of the Quality Assurance area, with the aim of offering students the possibility of […]

A brand is more than a logo. It’s the reflection of a company’s people, purpose, and potential. That’s why, before revealing our new branding to the world during the CPHI Europe event, we wanted to celebrate this milestone internally, with the people who bring Moehs to life every single day. In recent weeks, we hosted

After decades of steady growth, scientific excellence, and international expansion, Moehs Group has taken a bold step forward by unveiling a renewed brand identity — one that reflects not only who we are today, but also the path we’re committed to walking in the future. This rebranding is more than just a change of logo

For yet another year, CPHI Europe has proven to be one of the most important gatherings for the pharmaceutical industry—and for Moehs Group, it has been a particularly special edition. From October 28 to 30, our team was present in Frankfurt, actively participating in three days full of inspiring conversations, valuable meetings, and future-forward ideas.

Once again this year, we can announce the results obtained on the reduction of our carbon footprint. From Moehs Group, we continue to strive and work hard to fulfil our commitment to respect the environment. MOEHS GROUP SPAIN has achieved a reduction of absolute CO2eq emissions in its SCOPE1+2 of more than 25%, being this

At Moehs Group, we collaborate every year with the Aula d’Extensió Universitària de Rubí, an organization dedicated to bringing knowledge and culture closer to adults in the city. We are proud to be part of this project and to contribute to making education accessible to everyone, regardless of age. Through this collaboration, we support a

We are pleased to share that a study developed by Moehs’ Research and Development team has been published in the scientific journal Biomedical Chromatography. This research focuses on nitroso-duloxetine impurity, a compound classified as a potentially genotoxic impurity, reinforcing our commitment to pharmaceutical safety and innovation.   Given the stringent requirements for controlling nitrosamines at

During 2024, our photovoltaic plants generated a total of 1,628,153 kWh of energy, contributing significantly to the reduction of our carbon footprint: MOEHS CATALANA S.L.: 506,309 Kwh MOEHS CANTABRA S.L.: 479.156 Kwh MOEHS BCN S.L.: 457.979 Kwh MOEHS IBERICA S.L.: 184.709 Kwh A very positive environmental impact with a maximum compensation of 814 tons of

At Moehs Group, we continue to advance our commitment to sustainability as a member of the Pharmaceutical Supply Chain Initiative (PSCI). One of our priorities is to address the Pharmaceuticals in the Environment (PIE) challenge, focused on understanding, controlling and reducing the presence of active ingredients in industrial waters, thus protecting rivers, lakes and seas.

Last 10th of December, our Site Manager, Josep Mª Casanovas, presented how we work at Moehs Group to continuously improve in the efficient use of water and the implementation of sustainable practices. The presentation took place during the XXII Jornada de Normas de Correcta Fabricación de Medicamentos y Principios Activos, in Barcelona, an important event